ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

2015: “A Challenge For Our Generation,” AACR Says

July 18, 2003

New Toxicology Protocol Works, Predicts Safe starting Doses, Saves $1 Million

June 25, 1982

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

June 24, 1994

James Shannon, 89, Led NIH In 1960’s Period of Growth

May 27, 1994

DCE Board Approves Two New Grant Programs, New Contract, Recompetitions Totaling $22 Mil.

March 9, 1990

Other NCI funding opportunities listed.

July 9, 2004